Yong Zhang
10PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jan 02, 2026
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares.Xiaoyu Huang, Zhouao Zhang, Dan Liu
|Nov 28, 2025
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti-AChR Antibody-Positive Myasthenia Gravis: FGF-19 as a Novel Biomarker.Tiancheng Luo, Deyou Peng, Zhouao Zhang
|Jul 08, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China.Sushan Luo, Qilong Jiang, Wenshuang Zeng
|May 30, 2024
Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report.Zhouao Zhang, Mingjin Yang, Tiancheng Luo
|Apr 11, 2024
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.Yong Zhang, Dan Liu, Zhouao Zhang
|Jan 12, 2024
Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients.Xiaoyu Huang, Xueting An, Xue Gao
Pageof 2
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
